Spiro Getsios Selected Research

lethal acantholytic Epidermolysis bullosa

11/2010

Insights from a desmoplakin mutation identified in lethal acantholytic epidermolysis bullosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Spiro Getsios Research Topics

Disease

12	Neoplasms (Cancer) 01/2020 - 08/2003
6	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 03/2013
5	Inflammation (Inflammations) 01/2022 - 01/2013
2	Disease Progression 01/2022 - 08/2003
2	Infections 01/2020 - 11/2002
2	Skin Diseases (Skin Disease) 01/2019 - 01/2010
2	Wounds and Injuries (Trauma) 12/2014 - 02/2012
1	Parakeratosis 01/2022
1	Lung Diseases (Lung Disease) 01/2020
1	Infertility (Sterility) 01/2020
1	Pathologic Constriction (Stenosis) 01/2020
1	Hypoxia (Hypoxemia) 12/2014
1	Diffuse Palmoplantar Keratoderma (Tylosis) 08/2014
1	Staphylococcal Infections 08/2014
1	Fibrosis (Cirrhosis) 04/2014
1	Chronic Disease (Chronic Diseases) 04/2014
1	Chronic Pain 09/2011
1	Pain (Aches) 09/2011
1	Postherpetic Neuralgia 09/2011
1	Staphylococcal Scalded Skin Syndrome (Ritter's Disease) 12/2010
1	Impetigo (Impetigo Contagiosa) 12/2010
1	lethal acantholytic Epidermolysis bullosa 11/2010
1	Pemphigus (Pemphigus Vulgaris) 07/2010
1	Sunburn 04/2008
1	Neoplasm Metastasis (Metastasis) 12/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2004
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2004
1	Squamous Cell Carcinoma of Head and Neck 08/2004
1	Ovarian Neoplasms (Ovarian Cancer) 08/2003
1	Choriocarcinoma 05/2003

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
4	LigandsIBA 01/2017 - 02/2012
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
3	CytokinesIBA 01/2022 - 03/2013
3	Cadherins (E-Cadherin)IBA 01/2009 - 08/2003
2	EphrinsIBA 01/2014 - 02/2012
2	Messenger RNA (mRNA)IBA 03/2013 - 08/2003
2	Ephrin-A1 (Ephrin A1)IBA 03/2013 - 02/2012
1	Keratin-10IBA 01/2022
1	ElafinIBA 01/2022
1	Etanercept (Enbrel)FDA Link 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	loricrinIBA 01/2022
1	Hormones (Hormone)IBA 01/2020
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2020
1	Interleukin-17 ReceptorsIBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Hypoxia-Inducible Factor 1IBA 12/2014
1	Notch ReceptorsIBA 12/2014
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2014
1	TransglutaminasesIBA 08/2014
1	Estrogens (Estrogen)FDA Link 05/2014
1	Fibronectins (Fibronectin)IBA 04/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2014
1	EphA1 Receptor (Eph Receptor)IBA 01/2014
1	CalciumIBA 03/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2013
1	RetinoidsIBA 01/2013
1	Orphan Nuclear ReceptorsIBA 01/2013
1	Calcitonin Gene-Related PeptideIBA 09/2011
1	Peptides (Polypeptides)IBA 09/2011
1	Freund's AdjuvantIBA 09/2011
1	Peptide Hydrolases (Proteases)FDA Link 12/2010
1	Desmoplakins (Desmoplakin)IBA 11/2010
1	Desmosomal CadherinsIBA 01/2009
1	ApigeninIBA 04/2008
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2008
1	FlavonoidsIBA 04/2008
1	Annexin A5IBA 04/2008
1	Epidermal Growth Factor (EGF)IBA 12/2005
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2004
1	Tyrosine Kinase InhibitorsIBA 08/2004
1	ErbB Receptors (EGF Receptor)IBA 08/2004
1	Cetuximab (Erbitux)FDA Link 08/2004
1	PKI 166IBA 08/2004
1	beta CateninIBA 08/2003
1	Cell Adhesion MoleculesIBA 08/2003
1	osteoblast cadherinIBA 05/2003
1	TrypsinIBA 11/2002
1	AntibodiesIBA 11/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 07/2010
1	Ligation 09/2011
1	Subcutaneous Injections 09/2011